Fluticasone is associated with lower asthma-related costs than leukotriene modifiers in a real-world analysis (Q44131798)

From Wikidata
Jump to navigation Jump to search
scientific article published in September 2002
edit
Language Label Description Also known as
English
Fluticasone is associated with lower asthma-related costs than leukotriene modifiers in a real-world analysis
scientific article published in September 2002

    Statements

    Fluticasone is associated with lower asthma-related costs than leukotriene modifiers in a real-world analysis (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit